Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 3
1983 3
1984 3
1985 1
1986 1
1989 4
1990 1
1991 1
1992 1
1993 3
1994 3
1995 6
1996 5
1997 6
1998 6
1999 1
2000 2
2001 4
2002 5
2003 3
2004 7
2005 5
2006 10
2007 6
2008 9
2009 3
2010 10
2011 12
2012 11
2013 14
2014 11
2015 13
2016 12
2017 8
2018 3
2019 5
2020 3
2021 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

188 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
Le Gouill S, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Dartigeas C, Damaj G, Gastinne T, Ribrag V, Feugier P, Casasnovas O, Zerazhi H, Haioun C, Maisonneuve H, Houot R, Jardin F, Van Den Neste E, Tournilhac O, Le Dû K, Morschhauser F, Cartron G, Fornecker LM, Canioni D, Callanan M, Béné MC, Salles G, Tilly H, Lamy T, Gressin R, Hermine O; LYSA Group. Le Gouill S, et al. Among authors: canioni d. N Engl J Med. 2017 Sep 28;377(13):1250-1260. doi: 10.1056/NEJMoa1701769. N Engl J Med. 2017. PMID: 28953447 Free article. Clinical Trial.
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
Dubois S, Viailly PJ, Mareschal S, Bohers E, Bertrand P, Ruminy P, Maingonnat C, Jais JP, Peyrouze P, Figeac M, Molina TJ, Desmots F, Fest T, Haioun C, Lamy T, Copie-Bergman C, Brière J, Petrella T, Canioni D, Fabiani B, Coiffier B, Delarue R, Peyrade F, Bosly A, André M, Ketterer N, Salles G, Tilly H, Leroy K, Jardin F. Dubois S, et al. Among authors: canioni d. Clin Cancer Res. 2016 Jun 15;22(12):2919-28. doi: 10.1158/1078-0432.CCR-15-2305. Epub 2016 Jan 27. Clin Cancer Res. 2016. PMID: 26819451 Free article. Clinical Trial.
[Eosinophilic esophagitis].
Saillen E, Cellier C, Naneix AL, Canioni D, Bruneval P, Pouchot J, Georgin-Lavialle S. Saillen E, et al. Among authors: canioni d. Presse Med. 2014 Jan;43(1):34-8. doi: 10.1016/j.lpm.2013.03.012. Epub 2013 Jul 23. Presse Med. 2014. PMID: 23891531 Review. French.
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.
Morschhauser F, Le Gouill S, Feugier P, Bailly S, Nicolas-Virelizier E, Bijou F, Salles GA, Tilly H, Fruchart C, Van Eygen K, Snauwaert S, Bonnet C, Haioun C, Thieblemont C, Bouabdallah R, Wu KL, Canioni D, Meignin V, Cartron G, Houot R. Morschhauser F, et al. Among authors: canioni d. Lancet Haematol. 2019 Aug;6(8):e429-e437. doi: 10.1016/S2352-3026(19)30089-4. Epub 2019 Jul 8. Lancet Haematol. 2019. PMID: 31296423 Free article. Clinical Trial.
[Intestinal transplantation].
Yandza T, Schneider SM, Canioni D, Saint-Paul MC, Gugenheim J, Chevalier P, Goubaux B, Benchimol D, Hébuterne X. Yandza T, et al. Among authors: canioni d. Gastroenterol Clin Biol. 2007 May;31(5):469-79. doi: 10.1016/s0399-8320(07)89414-0. Gastroenterol Clin Biol. 2007. PMID: 17541336 Free article. Review. French.
[Pediatric non-Hodgkin lymphomas].
Brousse N, Vasiliu V, Michon J, Canioni D. Brousse N, et al. Among authors: canioni d. Ann Pathol. 2004 Dec;24(6):574-86. doi: 10.1016/s0242-6498(04)94020-5. Ann Pathol. 2004. PMID: 15785404 Review. French.
Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial.
Mounier N, El Gnaoui T, Tilly H, Canioni D, Sebban C, Casasnovas RO, Delarue R, Sonet A, Beaussart P, Petrella T, Castaigne S, Bologna S, Salles G, Rahmouni A, Gaulard P, Haioun C. Mounier N, et al. Among authors: canioni d. Haematologica. 2013 Nov;98(11):1726-31. doi: 10.3324/haematol.2013.090597. Epub 2013 Jun 10. Haematologica. 2013. PMID: 23753028 Free PMC article. Clinical Trial.
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O, Thiéblemont C, Bosly A, Laurent G, Morschhauser F, Ghesquières H, Jardin F, Bologna S, Fruchart C, Corront B, Gabarre J, Bonnet C, Janvier M, Canioni D, Jais JP, Salles G, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte. Récher C, et al. Among authors: canioni d. Lancet. 2011 Nov 26;378(9806):1858-67. doi: 10.1016/S0140-6736(11)61040-4. Lancet. 2011. PMID: 22118442 Free article. Clinical Trial.
Mast cell sarcoma: new cases and literature review.
Monnier J, Georgin-Lavialle S, Canioni D, Lhermitte L, Soussan M, Arock M, Bruneau J, Dubreuil P, Bodemer C, Chandesris MO, Lortholary O, Hermine O, Damaj G. Monnier J, et al. Among authors: canioni d. Oncotarget. 2016 Oct 4;7(40):66299-66309. doi: 10.18632/oncotarget.11812. Oncotarget. 2016. PMID: 27602777 Free PMC article. Review.
Gastrointestinal involvement and manifestations in systemic mastocytosis.
Sokol H, Georgin-Lavialle S, Grandpeix-Guyodo C, Canioni D, Barete S, Dubreuil P, Lortholary O, Beaugerie L, Hermine O. Sokol H, et al. Among authors: canioni d. Inflamm Bowel Dis. 2010 Jul;16(7):1247-53. doi: 10.1002/ibd.21218. Inflamm Bowel Dis. 2010. PMID: 20162539 Review.
188 results